ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,212Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 807

$455K Total Retail Price of All Prescriptions

Rank: 159 out of 807

543 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 543 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 11,912 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
LISINOPRIL 626 600 1 2
CITALOPRAM HBR 566 566 2 17
TRAZODONE HCL 542 542 3 25
FUROSEMIDE 449 441 4 6
OMEPRAZOLE 442 430 5 4
AMLODIPINE BESYLATE 403 402 6 5
METOPROLOL TARTRATE 361 353 7 8
LEVOTHYROXINE SODIUM 337 326 8 3
DONEPEZIL HCL 286 286 9 31
WARFARIN SODIUM 236 209 10 10
SIMVASTATIN 216 198 11 1
GABAPENTIN 209 207 12 16
ATENOLOL 189 188 13 7
RISPERIDONE 184 184 14 85
ALBUTEROL SULFATE 178 174 15 139
MIRTAZAPINE 174 164 16 38
METOPROLOL SUCCINATE 158 155 17 13
MAPAP 144 144 18 122
TAMSULOSIN HCL 142 142 19 27
QUETIAPINE FUMARATE 139 139 20 66
HYDROCHLOROTHIAZIDE 123 123 21 9
POTASSIUM CHLORIDE 122 121 22 18
NAMENDA 112 112 23 54
TRAMADOL HCL 112 108 23 19
DIVALPROEX SODIUM 111 111 25 114
SPIRONOLACTONE 111 107 25 48
IPRATROPIUM-ALBUTEROL 107 98 27 126
METFORMIN HCL 107 106 27 12
CYMBALTA 102 85 29 73
LANTUS 100 100 30 45
ASPIRIN 98 98 31 184
JANTOVEN 87 87 32 37
OLANZAPINE 86 86 33 119
POLYETHYLENE GLYCOL 3350 84 81 34 40
PREDNISONE 83 76 35 24
RANITIDINE HCL 83 83 35 34
AMMONIUM LACTATE 82 82 37 226
CARBIDOPA-LEVODOPA 81 81 38 64
DILTIAZEM ER 70 60 39 109
LOSARTAN POTASSIUM 69 69 40 14
SEROQUEL 67 67 41 155
ISOSORBIDE MONONITRATE ER 63 63 42 36
NOVOLOG 63 61 42 84
ARTIFICIAL TEARS 61 61 44 182
CHILDREN'S ASPIRIN 61 61 10 44 302
PAROXETINE HCL 61 59 44 49
KLOR-CON M10 61 60 44 156
NYSTOP 60 60 48 125
CARVEDILOL 58 56 49 35
DIOVAN 58 58 49 46
SERTRALINE HCL 58 58 49 22
CALCIUM WITH VITAMIN D 55 55 52 241
LACTULOSE 53 51 53 142
CLOPIDOGREL 52 52 54 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.